Lupin signs licensing deal with Alvion to market Cardiometabolic drugs in Southeast Asia region
By commercializing cardiometabolic drugs in the Southeast Asian region, Lupin will play a significant role in improving the quality of healthcare
By commercializing cardiometabolic drugs in the Southeast Asian region, Lupin will play a significant role in improving the quality of healthcare